In psychiatric therapy research, psychedelic-assisted psychotherapy is currently one of the most exciting areas of research. What trends could await us?
Some patients seek psychedelic-augmented psychotherapy with quite high expectations. How should therapists approach this?
If the intestinal microbiome is unbalanced, chronic diseases or micro-inflammations often ensue. What role does intestinal flora dysfunction play in grade III obesity?
A 20-year-old woman arrives to the emergency room with lower abdominal pain and changes in bowel movements. What is your probable diagnosis?
In this interview, Dr. Beed's global snapshot of today's psychedelics research covers therapeutics, policies, patient-doctor relations, and medical specialties.
Artificial intelligence has also arrived in the operating room. Will it replace surgeons in the future?
Prof. Dr. Matthew Johnson looks at the challenges posed to psychedelics science professionals by patients' experiences and experimental settings.
Dr Henrik Jungaberle covers the INSIGHT 2023 themes, and the importance of scientific rigour in the expanding field of psychedelic therapy.
Research is evaluating risks and suitability of MDMA assisted therapy for 15-17 year olds with PTSD. Ethically rigorous studies are needed to evaluate safety and efficacy.
The two pilot studies, one on depression in Alzheimer's and one on Lyme disease, assess if psilocybin offers alternatives to ineffective standard treatments.
Five new guidelines were presented in the ESC Congress: acute coronary syndromes; heart failure; cardiomyopathies; cardio-vascular disease and diabetes; and endocarditis.
Where does Italy stand in psychedelic drug research? We discuss this with Dr Matteo Buonarroti, the first Italian doctor to complete the Mind Foundation's Augmented Psychotherapy Training.
Cardiovascular events are the number one cause of death. Guidelines for all acute coronary syndromes have been published just in time for the 2023 ESC Congress.
The experiment, sent to the ISS, looks into the molecular mechanism behind an innovative pharmaceutical protocol to combat prion diseases.
Drowning deaths are a serious public health problem worldwide. Drowning victims require rapid and skilled intervention.
Severe congenital neutropenia increases the risk of myelodysplastic syndrome and acute myeloid leukaemia. What do we know today about the haematological processes that lead to leukaemogenesis?
No drug tackled the cause of ATTR-CM - the deposition of misfolded transthyretin in the heart muscle tissue. Until a phase I study tested a new recombinant antibody.
A meta-analysis examined the timing of postoperative thromboembolic events. What are the implications of this research for treatments?
More data suggests a link between exposure to environmental toxins such as pesticides and heavy metals, and the rise of Parkinson's disease.
Recent studies show the benefit of renal denervation in severe or refractory hypertension. The ESH has started recommending it for some patients.